Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation
Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation
Ver/Abrir
Este documento contiene ficheros embargados hasta el dia 31-08-2025
Autor/a
Artigues Cladera, Margalida
Hernández Hernández, Marta
Borrós i Gómez, Salvador
Fornaguera Puigvert, Cristina
Otros/as autores/as
Universitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
Universitat Ramon Llull. IQS
Fecha de publicación
2023-09Resumen
Doxorubicin (DOX) is amongst the most widely used chemotherapeutic drugs against various cancers. However,
its controlled biodistribution to the tumor site at the required pharmacokinetics profile remains challenging. In
this work, a vast study of formulation parameters has been performed to control doxorubicin loading into
polymeric nanoparticles in physiological conditions. Water-in-oil-in-water (W1/O/W2) template emulsions have
been formulated, including doxorubicin in the internal water phase. Specifically, the system [Doxorubicin in
aqueous solution (W1) / Pluronic F-127 (S) and PLGA in ethyl acetate (O)], [Polysorbate 80 (S) in water solution],
using phosphate buffer on both aqueous phases at different electrolyte concentrations has been established.
The first W1/O nano-emulsion was formed by high-speed homogenization, and the second O/W2 nano-emulsion
was formed by the phase inversion composition method, a low-energy emulsification appropriated for pharmaceutical
compounds. Although many previous studies had already used double emulsions for DOX encapsulation
in nanofluids, here, for the first time, the salt concentration of the water phases has been varied to control
the resulting doxorubicin and nanoparticle properties. The addition of high concentrations of electrolytes in both
aqueous phases decreases the solubility and dissolution rates of the drug, leading to a high degree of DOX
dimerization. This phenomenon significantly impacts the internalization and subcellular localization. Facilitating
drug nuclear accumulation is of vital interest, and this is primarily achieved when doxorubicin is incorporated
into nanoparticles formulated with PBS at low electrolyte concentrations (2.5 mM), which exhibit exceptional
internalization properties. Thus, it has been demonstrated that doxorubicin loading in polymeric nanoparticles
can be tuned by only varying salt concentrations of template W1/O/W2 emulsions. Consequently, our results
show the adequacy of the double nano-emulsion templating for the generation of non-toxic DOX-loaded polymeric
nanoparticles with different physicochemical properties and interaction with the cell surface that would
allow their use for various anticancer therapies.
Tipo de documento
Artículo
Versión del documento
Versión aceptada
Lengua
English
Materias (CDU)
615 - Farmacología. Terapéutica. Toxicología. Radiología
616 - Patología. Medicina clínica. Oncología
Palabras clave
Emulsions
Farmàcia
Nanopartícules
Nanomedicina
Duxorubicina
Càncer -- Tractament
Water-in-oil-in-water emulsions
Double emulsions
Nano-emulsions
Polymeric nanoparticles
Doxorubicin encapsulation
Antitumor therapies
Páginas
12 p.
Publicado por
Elsevier
Publicado en
Journal of Molecular Liquids, 2023, vol. 390, part A, 122986
Número del acuerdo de la subvención
info:eu-repo/grantAgreement/MICIN-AEI/PID2021-125910OB-I00
info:eu-repo/grantAgreement/MICIN-AEI/10.13039/501100011033
info:eu-repo/grantAgreement/SUR del DEC/SGR/2021 SGR 00537
Este ítem aparece en la(s) siguiente(s) colección(ones)
Derechos
© Elsevier
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-nd/4.0/